Fig. 3: A novel risk score to predict severe infections/death during novel agent-based induction therapy in transplant-eligible NDMM patients. | Leukemia

Fig. 3: A novel risk score to predict severe infections/death during novel agent-based induction therapy in transplant-eligible NDMM patients.

From: Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients

Fig. 3

A Bar plots on incidence of severe infections, death, or both during induction therapy within the low-, intermediate- and high-risk groups in the training cohort. B Incidence of severe infections during induction therapy within the low-, intermediate- and high-risk groups. C Incidence of death during induction therapy within the low-, intermediate- and high-risk groups. D Incidence of severe infections/death during induction therapy within the low-, intermediate-, and high-risk groups. NDMM newly diagnosed multiple myeloma.

Back to article page